Dynamic Nanostructures for Conditional Activation and Deactivation of Biological Pathways

Area of Science:

• Nucleic acid nanotechnology
• Molecular biology
• Gene therapy

Background:

• Nucleic acid nanotechnology enables the creation of versatile nucleic acid nanoparticles (NANPs).
• These NANPs can be functionalized with various molecules, including decoys that inhibit gene transcription.
• The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is implicated in inflammatory diseases and cancer.

Purpose of the Study:

• To develop and characterize NF-κB decoy fibers for therapeutic applications.
• To provide a detailed protocol for synthesizing and validating these novel gene regulatory agents.

Main Methods:

• Synthesis of interdependent self-recognizing hybridized DNA/RNA fibers.
• Characterization using polyacrylamide gel electrophoresis (PAGE) for purity and physicochemical properties.
• Functional bioassays to confirm biological activity in decoying NF-κB.

Main Results:

• Successful synthesis of NF-κB decoy fibers with confirmed purity and properties via PAGE.
• Demonstrated biological activity of decoy fibers in preventing NF-κB interaction with target gene promoters.
• Validation of the therapeutic potential of NF-κB decoying for gene regulation.

Conclusions:

• NF-κB decoy fibers represent a viable strategy for gene regulation and therapy.
• The described protocol facilitates the reproducible synthesis and characterization of these therapeutic agents.
• This approach holds promise for treating NF-κB-mediated inflammatory diseases and cancers.